152 related articles for article (PubMed ID: 23591524)
1. Effects of the Smad4 C324Y mutation on thyroid cell proliferation.
D'Inzeo S; Nicolussi A; Nardi F; Coppa A
Int J Oncol; 2013 Jun; 42(6):1890-6. PubMed ID: 23591524
[TBL] [Abstract][Full Text] [Related]
2. A novel human Smad4 mutation is involved in papillary thyroid carcinoma progression.
D'Inzeo S; Nicolussi A; Donini CF; Zani M; Mancini P; Nardi F; Coppa A
Endocr Relat Cancer; 2012 Feb; 19(1):39-55. PubMed ID: 22109972
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.
Geraldo MV; Yamashita AS; Kimura ET
Oncogene; 2012 Apr; 31(15):1910-22. PubMed ID: 21874046
[TBL] [Abstract][Full Text] [Related]
4. Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer.
Garcia-Rendueles AR; Rodrigues JS; Garcia-Rendueles ME; Suarez-Fariña M; Perez-Romero S; Barreiro F; Bernabeu I; Rodriguez-Garcia J; Fugazzola L; Sakai T; Liu F; Cameselle-Teijeiro J; Bravo SB; Alvarez CV
Oncogene; 2017 Feb; 36(5):652-666. PubMed ID: 27452523
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase A modulates transforming growth factor-β signaling through a direct interaction with Smad4 protein.
Yang H; Li G; Wu JJ; Wang L; Uhler M; Simeone DM
J Biol Chem; 2013 Mar; 288(12):8737-8749. PubMed ID: 23362281
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta/Smad pathway and BRAF mutation play different roles in circumscribed and infiltrative papillary thyroid carcinoma.
Eloy C; Santos J; Cameselle-Teijeiro J; Soares P; Sobrinho-Simões M
Virchows Arch; 2012 Jun; 460(6):587-600. PubMed ID: 22527019
[TBL] [Abstract][Full Text] [Related]
7. Role of reduced expression of SMAD4 in papillary thyroid carcinoma.
D'Inzeo S; Nicolussi A; Ricci A; Mancini P; Porcellini A; Nardi F; Coppa A
J Mol Endocrinol; 2010 Oct; 45(4):229-44. PubMed ID: 20685810
[TBL] [Abstract][Full Text] [Related]
8. Coordinated regulation of Rap1 and thyroid differentiation by cyclic AMP and protein kinase A.
Tsygankova OM; Saavedra A; Rebhun JF; Quilliam LA; Meinkoth JL
Mol Cell Biol; 2001 Mar; 21(6):1921-9. PubMed ID: 11238928
[TBL] [Abstract][Full Text] [Related]
9. Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells.
Thacker PC; Karunagaran D
PLoS One; 2015; 10(3):e0120045. PubMed ID: 25786122
[TBL] [Abstract][Full Text] [Related]
10. A thyroid-specific far-upstream enhancer in the human sodium/iodide symporter gene requires Pax-8 binding and cyclic adenosine 3',5'-monophosphate response element-like sequence binding proteins for full activity and is differentially regulated in normal and thyroid cancer cells.
Taki K; Kogai T; Kanamoto Y; Hershman JM; Brent GA
Mol Endocrinol; 2002 Oct; 16(10):2266-82. PubMed ID: 12351692
[TBL] [Abstract][Full Text] [Related]
11. Sox9 is involved in the thyroid differentiation program and is regulated by crosstalk between TSH, TGFβ and thyroid transcription factors.
López-Márquez A; Carrasco-López C; Martínez-Cano A; Lemoine P; Pierreux CE; Santisteban P
Sci Rep; 2022 Feb; 12(1):2144. PubMed ID: 35140269
[TBL] [Abstract][Full Text] [Related]
12. Differential utilization of cyclin D1 and cyclin D3 in the distinct mitogenic stimulations by growth factors and TSH of human thyrocytes in primary culture.
Paternot S; Dumont JE; Roger PP
Mol Endocrinol; 2006 Dec; 20(12):3279-92. PubMed ID: 16916940
[TBL] [Abstract][Full Text] [Related]
13. Restoration of Smad4 in BxPC3 pancreatic cancer cells attenuates proliferation without altering angiogenesis.
Yasutome M; Gunn J; Korc M
Clin Exp Metastasis; 2005; 22(6):461-73. PubMed ID: 16320109
[TBL] [Abstract][Full Text] [Related]
14. Epithelial rat thyroid cell clones, escaping from transforming growth factor beta negative growth control, are still inhibited by this factor in the ability to trap iodide.
Coppa A; Mincione G; Mammarella S; Ranieri A; Colletta G
Cell Growth Differ; 1995 Mar; 6(3):281-90. PubMed ID: 7794796
[TBL] [Abstract][Full Text] [Related]
15. Mutations in protein-binding hot-spots on the hub protein Smad3 differentially affect its protein interactions and Smad3-regulated gene expression.
Schiro MM; Stauber SE; Peterson TL; Krueger C; Darnell SJ; Satyshur KA; Drinkwater NR; Newton MA; Hoffmann FM
PLoS One; 2011; 6(9):e25021. PubMed ID: 21949838
[TBL] [Abstract][Full Text] [Related]
16. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.
Qiu W; Schönleben F; Li X; Su GH
Cancer Lett; 2007 Jan; 245(1-2):163-70. PubMed ID: 16478646
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin regulates thyroid cell proliferation by up-regulating miR-23b and miR-29b that target SMAD3.
Leone V; D'Angelo D; Pallante P; Croce CM; Fusco A
J Clin Endocrinol Metab; 2012 Sep; 97(9):3292-301. PubMed ID: 22730517
[TBL] [Abstract][Full Text] [Related]
18. The cAMP/PKA/CREB and TGFβ/SMAD4 Pathways Regulate Stemness and Metastatic Potential in Colorectal Cancer Cells.
Fujishita T; Kojima Y; Kajino-Sakamoto R; Mishiro-Sato E; Shimizu Y; Hosoda W; Yamaguchi R; Taketo MM; Aoki M
Cancer Res; 2022 Nov; 82(22):4179-4190. PubMed ID: 36066360
[TBL] [Abstract][Full Text] [Related]
19. Reduction of invasive potential in K-ras-transformed thyroid cells by restoring of TGF-beta pathway.
Nicolussi A; D'Inzeo S; Gismondi A; Coppa A
Clin Exp Metastasis; 2006; 23(5-6):237-48. PubMed ID: 17086361
[TBL] [Abstract][Full Text] [Related]
20. A transforming growth factor beta-induced Smad3/Smad4 complex directly activates protein kinase A.
Zhang L; Duan CJ; Binkley C; Li G; Uhler MD; Logsdon CD; Simeone DM
Mol Cell Biol; 2004 Mar; 24(5):2169-80. PubMed ID: 14966294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
